With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Single Cell Signaling Profiles In High-Risk Pediatric Leukemia||Stanford University / Kara Davis||Young Investigator Grants||2010||California|
|Genomic Alterations in Medulloblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Young Investigator Grants||2008||California|
|Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma||The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD||'A' Award Grants||2019||California|
|Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation||Stanford University School of Medicine / Yuan Pan, PhD||Young Investigator Grants||2020||California|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Identifying New Therapeutic Targets in Fibrolamellar Hepatocellular Carcinoma||Stanford University / Julien Sage, PhD||Innovation Grants||2018||California|
|Single Cell Analysis of Leukemia Initiation||Stanford University / Michael Cleary, MD||Innovation Grants||2015||California|
|Neural Crest Gene Regulatory Networks Underlying Normal Meningeal Development and Onset of Meningioma||California Institute of Technology / Ayyappa Raja Desingu Rajan, PhD||Young Investigator Grants||2021||California|
|Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model||Stanford University / Michelle Monje, MD/PhD||Innovation Grants||2016||California|
|In-vivo characterization of MYCN-driven immunosuppression||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2021||California|